Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
No Thumbnail Available
Authors
Goncalves, I.
Bengtsson, E.
Colhoun, H. M.
Shore, Angela
Palombo, C.
Natali, A.
Edsfeldt, A.
Dunér, P.
Fredrikson, G. N.
Björkbacka, H.
Journal
Arteriosclerosis, thrombosis, and vascular biology
Type
Journal Article
Research Support, Non-U.S. Gov't
Research Support, Non-U.S. Gov't
Publisher
American Heart Association
Rights
Archived with thanks to Arteriosclerosis, thrombosis, and vascular biology
Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins and play important roles in development and tissue repair. They have also been shown to have both protective and pathogenic effects in atherosclerosis, and experimental studies have suggested that MMP-12 contributes to plaque growth and destabilization. The objective of this study was to investigate the associations between circulating MMPs, atherosclerosis burden, and incidence of cardiovascular disease with a particular focus on type 2 diabetes mellitus.
Citation
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes. 2015, 35 (7):1723-31 Arterioscler. Thromb. Vasc. Biol.
Note
This article is freely available online. Click on the 'Additional Link' above to access the full-text via the publisher's site.